Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
52%
ALSO IN BBP
BBP
67
HOLDINGS
40%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 4.2% | 1.6% | 1.6% |
|
INCYTE CORP | 1.6% | 1.6% | 1.6% |
|
AMGEN INC | 3.4% | 1.6% | 1.6% |
|
GILEAD SCIENCES INC | 3.2% | 1.6% | 1.6% |
|
BIOGEN IDEC INC | 4.2% | 1.6% | 1.6% |
FTXH Overweight Relative to BBP
|
MERCK & CO. INC. | 8.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.2% |
|
JOHNSON & JOHNSON | 7.0% |
|
ABBVIE INC | 6.3% |
|
PFIZER INC | 6.2% |
|
ELI LILLY & CO | 4.4% |
|
CARDINAL HEALTH INC | 4.1% |
|
VIATRIS, INC. | 3.7% |
|
BIOGEN IDEC INC | 2.6% |
|
REGENERON PHARMACEUTICALS | 2.5% |
FTXH Underweight Relative to BBP
|
DYNAVAX TECHNOLOGIES CORP | -2.2% |
|
AMICUS THERAPEUTICS INC | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.9% |
|
AXSOME THERAPEUTICS, INC. | -1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.7% |
|
TRAVERE THERAPEUTICS, INC. | -1.7% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
SYNDAX PHARMACEUTICALS INC | -1.6% |
|
BIOCRYST PHARMACEUTICALS INC | -1.6% |